Gap finder
Search review questions
Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Every word you type has to appear somewhere in the question, and the closest matches are ranked first.
15,213 questions in 2,394 reviews
current versionsNo studies 15,213 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
External pneumatic intermittent compression vs rest Symptoms associated with varicose veins and oedema · Pregnant women with varicose veins and leg oedema in pregnancy Interventions for varicose veins and leg oedema in pregnancy (2015) · Cochrane | no estimate extracted | NR | No studies |
Interferon beta‐1a vs placebo Change in timed walk at 6 months (%) e.g. 10‐metre or 6‐minute walk test at 6 months ‐ not measured · people with inclusion body myositis Treatment for inclusion body myositis (2015) · Cochrane | no estimate extracted | NR | No studies |
Methotrexate vs placebo Change in muscle mass at 6 months (%) ‐ not measured · people with inclusion body myositis Treatment for inclusion body myositis (2015) · Cochrane | no estimate extracted | NR | No studies |
Methotrexate vs placebo Change in handgrip strength at 6 months (%) ‐ not measured · people with inclusion body myositis Treatment for inclusion body myositis (2015) · Cochrane | no estimate extracted | NR | No studies |
Methotrexate vs placebo Change in timed walk at 6 months (%) e.g. 10‐metre or 6‐minute walk test at 6 months ‐ not measured · people with inclusion body myositis Treatment for inclusion body myositis (2015) · Cochrane | no estimate extracted | NR | No studies |
Intravenous immunoglobulin vs placebo Change in muscle strength at 12 months (%) ‐ not measured · people with inclusion body myositis Treatment for inclusion body myositis (2015) · Cochrane | no estimate extracted | NR | No studies |
Methotrexate and anti‐T lymphocyte immunoglobulin vs methotrexate Change in muscle mass at 12 months (%) ‐ not measured · people with inclusion body myositis Treatment for inclusion body myositis (2015) · Cochrane | no estimate extracted | NR | No studies |
Methotrexate and anti‐T lymphocyte immunoglobulin vs methotrexate Change in timed walk at 6 months (%) e.g. 10‐metre or 6‐minute walk test at 6 months ‐ not measured · people with inclusion body myositis Treatment for inclusion body myositis (2015) · Cochrane | no estimate extracted | NR | No studies |
Methotrexate and azathioprine vs methotrexate (plus leucovorin) Change in muscle strength at 12 months (%) (using MMT or QMT) at 12 months ‐ not measured · people with inclusion body myositis Treatment for inclusion body myositis (2015) · Cochrane | no estimate extracted | NR | No studies |
Methotrexate and azathioprine vs methotrexate (plus leucovorin) Change in muscle mass at 6 months (%) ‐ not measured · people with inclusion body myositis Treatment for inclusion body myositis (2015) · Cochrane | no estimate extracted | NR | No studies |
Methotrexate and azathioprine vs methotrexate (plus leucovorin) Change in handgrip strength at 6 months (%) ‐ not measured · people with inclusion body myositis Treatment for inclusion body myositis (2015) · Cochrane | no estimate extracted | NR | No studies |
Methotrexate and azathioprine vs methotrexate (plus leucovorin) Change in timed walk at 6 months (%) e.g. 10‐metre or 6‐minute walk test at 6 months ‐ not measured · people with inclusion body myositis Treatment for inclusion body myositis (2015) · Cochrane | no estimate extracted | NR | No studies |
Intravenous immunoglobulin vs placebo Change in muscle mass at 6 months (%) ‐ not measured · people with inclusion body myositis Treatment for inclusion body myositis (2015) · Cochrane | no estimate extracted | NR | No studies |
Oxandrolone vs placebo Change in muscle strength at 12 months (%) ‐ not measured · people with inclusion body myositis Treatment for inclusion body myositis (2015) · Cochrane | no estimate extracted | NR | No studies |
Oxandrolone vs placebo Change in handgrip strength at 6 months (%) ‐ not measured · people with inclusion body myositis Treatment for inclusion body myositis (2015) · Cochrane | no estimate extracted | NR | No studies |
Oxandrolone vs placebo Change in timed walk at 6 months (%) e.g. 10‐metre or 6‐minute walk test at 6 months ‐ not measured · people with inclusion body myositis Treatment for inclusion body myositis (2015) · Cochrane | no estimate extracted | NR | No studies |
Oxandrolone vs placebo Significant adverse events · people with inclusion body myositis Treatment for inclusion body myositis (2015) · Cochrane | no estimate extracted | NR | No studies |
Intravenous immunoglobulin vs placebo Change in handgrip strength at 6 months (%) ‐ not measured · people with inclusion body myositis Treatment for inclusion body myositis (2015) · Cochrane | no estimate extracted | NR | No studies |
Intravenous immunoglobulin vs placebo Change in timed walk at 6 months (%) e.g. 10‐metre or 6‐minute walk test at 6 months ‐ not measured · people with inclusion body myositis Treatment for inclusion body myositis (2015) · Cochrane | no estimate extracted | NR | No studies |
Interferon beta‐1a vs placebo Change in muscle strength at 12 months (%) ‐ not measured · people with inclusion body myositis Treatment for inclusion body myositis (2015) · Cochrane | no estimate extracted | NR | No studies |
Treatment of UI after radical: combinations of treatments vs no treatment Economic Analysis using QALY ‐ not reported · patients with postprostatectomy UI Conservative management for postprostatectomy urinary incontinence (2015) · Cochrane | no estimate extracted | NR | No studies |
Prevention of UI after radical: PFMT ± biofeedback vs no treatment Adverse events ‐ not reported · All men after radical prostatectomy Conservative management for postprostatectomy urinary incontinence (2015) · Cochrane | no estimate extracted | NR | No studies |
Prevention of UI after radical: PFMT ± biofeedback vs no treatment Economic analysis using QALY ‐ not reported · All men after radical prostatectomy Conservative management for postprostatectomy urinary incontinence (2015) · Cochrane | no estimate extracted | NR | No studies |
Prevention of UI after radical: electric or magnetic energy vs no treatment Number of incontinent men after 12 months ‐ not reported · All men after radical prostatectomy Conservative management for postprostatectomy urinary incontinence (2015) · Cochrane | no estimate extracted | NR | No studies |
Prevention of UI after radical: electric or magnetic energy vs no treatment Adverse events ‐ not reported · All men after radical prostatectomy Conservative management for postprostatectomy urinary incontinence (2015) · Cochrane | no estimate extracted | NR | No studies |
Prevention of UI after radical: electric or magnetic energy vs no treatment Economic analysis using QALY ‐ not reported · All men after radical prostatectomy Conservative management for postprostatectomy urinary incontinence (2015) · Cochrane | no estimate extracted | NR | No studies |
Prevention of UI after radical: combinations of treatments vs no treatment Quality of life Score assessed using (ICIQ‐SF) or (ICIQ‐ SF UI score) ‐ not reported · All men after radical prostatectomy Conservative management for postprostatectomy urinary incontinence (2015) · Cochrane | no estimate extracted | NR | No studies |
Prevention of UI after radical: combinations of treatments vs no treatment Adverse events ‐ not reported · All men after radical prostatectomy Conservative management for postprostatectomy urinary incontinence (2015) · Cochrane | no estimate extracted | NR | No studies |
Prevention of UI after radical: combinations of treatments vs no treatment Economic analysis using QALY ‐ not reported · All men after radical prostatectomy Conservative management for postprostatectomy urinary incontinence (2015) · Cochrane | no estimate extracted | NR | No studies |
Prevention of UI after radical: one active treatment vs another active treatment (PFMT pre and post‐operation versus PFMT post‐operation) Quality of Life Score assessed using (ICIQ‐SF) or (ICIQ‐SF UI score) after 12 months ‐ not reported · All men after radical prostatectomy Conservative management for postprostatectomy urinary incontinence (2015) · Cochrane | no estimate extracted | NR | No studies |
Prevention of UI after radical: one active treatment vs another active treatment (PFMT pre and post‐operation versus PFMT post‐operation) Economic Analysis using QALY ‐ not reported · All men after radical prostatectomy Conservative management for postprostatectomy urinary incontinence (2015) · Cochrane | no estimate extracted | NR | No studies |
Prevention of UI after radical: one active treatment vs another active treatment (PFMT + penile vibration pre and post‐operation versus PFMT pre and post‐operation) Economic analysis using QALY ‐ not reported · All men after radical prostatectomy Conservative management for postprostatectomy urinary incontinence (2015) · Cochrane | no estimate extracted | NR | No studies |
Prevention of UI after radical: one active treatment vs another active treatment (pre‐operative PFMT + electrical stimulation versus pre‐operative PFMT) Number of incontinent men after 12 months ‐ not reported · All men after radical prostatectomy Conservative management for postprostatectomy urinary incontinence (2015) · Cochrane | no estimate extracted | NR | No studies |
Treatment of UI after radical: PFMT ± biofeedback vs no treatment; Economic analysis using QALY ‐ not reported · patients with postprostatectomy urinary incontinence Conservative management for postprostatectomy urinary incontinence (2015) · Cochrane | no estimate extracted | NR | No studies |
Prevention of UI after radical: one active treatment vs another active treatment (pre‐operative PFMT + electrical stimulation versus pre‐operative PFMT) Adverse events ‐ not reported · All men after radical prostatectomy Conservative management for postprostatectomy urinary incontinence (2015) · Cochrane | no estimate extracted | NR | No studies |
Prevention of UI after radical: one active treatment vs another active treatment (pre‐operative PFMT + electrical stimulation versus pre‐operative PFMT) Economic analysis using QALY ‐ not reported · All men after radical prostatectomy Conservative management for postprostatectomy urinary incontinence (2015) · Cochrane | no estimate extracted | NR | No studies |
Treatment of UI after TURP: PFMT ± biofeedback vs no treatment Adverse events ‐ not reported · Men with UI after TURP Conservative management for postprostatectomy urinary incontinence (2015) · Cochrane | no estimate extracted | NR | No studies |
Treatment of UI after TURP: PFMT ± biofeedback vs no treatment Economic analysis using QALY ‐ not reported · Men with UI after TURP Conservative management for postprostatectomy urinary incontinence (2015) · Cochrane | no estimate extracted | NR | No studies |
Prevention of UI after TURP: pre or post‐operative PFMT ± biofeedback vs no treatment Urinary Incontinence Score assessed using (ICIQ‐SF) or (ICIQ‐SF UI score) at 12 months ‐ not reported · All men after TURP Conservative management for postprostatectomy urinary incontinence (2015) · Cochrane | no estimate extracted | NR | No studies |
Prevention of UI after TURP: pre or post‐operative PFMT ± biofeedback vs no treatment Adverse events ‐ not reported · All men after TURP Conservative management for postprostatectomy urinary incontinence (2015) · Cochrane | no estimate extracted | NR | No studies |
Prevention of UI after TURP: pre or post‐operative PFMT ± biofeedback vs no treatment Economic analysis using QALY ‐ not reported · All men after TURP Conservative management for postprostatectomy urinary incontinence (2015) · Cochrane | no estimate extracted | NR | No studies |
Treatment of UI after radical: electric or magnetic energy vs no treatment Economic analysis using QALY ‐ not reported · Patients with postprostatectomy UI Conservative management for postprostatectomy urinary incontinence (2015) · Cochrane | no estimate extracted | NR | No studies |
Biofeedback vs usual care Adverse events post‐intervention ‐ not reported · patients with fibromyalgia Mind and body therapy for fibromyalgia (2015) · Cochrane | no estimate extracted | NR | No studies |
Mindfulness vs usual care Adverse events post‐intervention ‐ not reported · patients with fibromyalgia Mind and body therapy for fibromyalgia (2015) · Cochrane | no estimate extracted | NR | No studies |
Relaxation vs usual care Adverse events post‐intervention ‐ not reported · patients with fibromyalgia Mind and body therapy for fibromyalgia (2015) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Treatment comparisons · trial participants with dendritic or geographic epithelial keratitis Outcomes: corneal epithelial healing at 7 and 14… Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis (2015) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Treatment comparisons · trial participants with dendritic or geographic epithelial keratitis Outcomes: corneal epithelial healing at 7 and 14… Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis (2015) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Treatment comparisons · trial participants with dendritic or geographic epithelial keratitis Outcomes: corneal epithelial healing at 7 and 14… Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis (2015) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Treatment comparisons · trial participants with dendritic or geographic epithelial keratitis Outcomes: corneal epithelial healing at 7 and 14… Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis (2015) · Cochrane | no estimate extracted | NR | No studies |
SSRIs or SNRIs vs amitriptyline Symptomatic/analgesic medication use for acute headache attacks · patients for whom migraine preventive interventions are indicated Selective serotonin reuptake inhibitors (SSRIs) and serotonin‐norepinephrine reuptake inhibitors (SNRIs) for… (2015) · Cochrane | no estimate extracted | NR | No studies |